Yuxi Lin, PhD

TitleIntellectual Property OFCR 3
InstitutionUniversity of California San Francisco
DepartmentInnovation Ventures
Address600 16th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Chicago, Chicago, ILBA06/2010Biological Sciences
    Columbia University, New York City, NYPhD06/2016Biomedical Sciences
    University of California, San Francisco, San Francisco, CAPostdoctoral Fellowship03/2018

    Collapse Research 
    Collapse Research Activities and Funding
    NASA Postdoctoral Program Fellowship
    NASA Aug 1, 2016
    Role: Fellow
    Role Description: (Declined)
    Brown adipose tissue lysosomal and neutral lipases in nonshivering thermogenesis
    NIH F31DK105723Jul 23, 2015 - Jul 22, 2017
    Role: Principal Investigator
    Med into Grad
    HHMI May 1, 2012
    Role: Fellow

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Huebener P, Gwak GY, Pradere JP, Quinzii CM, Friedman R, Lin CS, Trent CM, Mederacke I, Zhao E, Dapito DH, Lin Y, Goldberg IJ, Czaja MJ, Schwabe RF. High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab. 2014 Mar 04; 19(3):539-47. PMID: 24606906; PMCID: PMC4099361.
    2. Neel BA, Lin Y, Pessin JE. Skeletal muscle autophagy: a new metabolic regulator. Trends Endocrinol Metab. 2013 Dec; 24(12):635-43. PMID: 24182456; PMCID: PMC3849822.
    3. Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, Brady MJ. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60. PMID: 22387882; PMCID: PMC3338892.